Zoetis price target lowered to $200 from $205 at BofA

BofA analyst Michael Ryskin lowered the firm’s price target on Zoetis to $200 from $205 and keeps a Buy rating on the shares. Ahead of Q1 earnings, the firm revisited some of its models and updated for recent data points and trends among its Animal Health coverage. While noting that its coverage “skews generally negative heading into the prints,” the firm adds that a number of broader market and company-specific headwinds have been reflected in the group’s marked underperformance year-to-date.